Literature DB >> 25288561

RAD51AP1-deficiency in vertebrate cells impairs DNA replication.

Ann C Parplys1, Katja Kratz1, Michael C Speed1, Stanley G Leung1, David Schild2, Claudia Wiese3.   

Abstract

RAD51-associated protein 1 (RAD51AP1) is critical for homologous recombination (HR) by interacting with and stimulating the activities of the RAD51 and DMC1 recombinases. In human somatic cells, knockdown of RAD51AP1 results in increased sensitivity to DNA damaging agents and to impaired HR, but the formation of DNA damage-induced RAD51 foci is unaffected. Here, we generated a genetic model system, based on chicken DT40 cells, to assess the phenotype of fully inactivated RAD51AP1 in vertebrate cells. Targeted inactivation of both RAD51AP1 alleles has no effect on either viability or doubling-time in undamaged cells, but leads to increased levels of cytotoxicity after exposure to cisplatin or to ionizing radiation. Interestingly, ectopic expression of GgRAD51AP1, but not of HsRAD51AP1 is able to fully complement in cell survival assays. Notably, in RAD51AP1-deficient DT40 cells the resolution of DNA damage-induced RAD51 foci is greatly slowed down, while their formation is not impaired. We also identify, for the first time, an important role for RAD51AP1 in counteracting both spontaneous and DNA damage-induced replication stress. In human and in chicken cells, RAD51AP1 is required to maintain wild type speed of replication fork progression, and both RAD51AP1-depleted human cells and RAD51AP1-deficient DT40 cells respond to replication stress by a slow-down of replication fork elongation rates. However, increased firing of replication origins occurs in RAD51AP1-/- DT40 cells, likely to ensure the timely duplication of the entire genome. Taken together, our results may explain why RAD51AP1 commonly is overexpressed in tumor cells and tissues, and we speculate that the disruption of RAD51AP1 function could be a promising approach in targeted tumor therapy.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA replication; DT40 cells; Homologous recombination; RAD51 foci; RAD51AP1

Mesh:

Substances:

Year:  2014        PMID: 25288561      PMCID: PMC4254361          DOI: 10.1016/j.dnarep.2014.09.007

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  43 in total

1.  Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.

Authors:  Bing Xia; Qing Sheng; Koji Nakanishi; Akihiro Ohashi; Jianmin Wu; Nicole Christ; Xinggang Liu; Maria Jasin; Fergus J Couch; David M Livingston
Journal:  Mol Cell       Date:  2006-06-23       Impact factor: 17.970

2.  Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma.

Authors:  Christophe Rosty; Michal Sheffer; Dafna Tsafrir; Nicolas Stransky; Ilan Tsafrir; Martine Peter; Patricia de Crémoux; Anne de La Rochefordière; Rémy Salmon; Thierry Dorval; Jean Paul Thiery; Jérôme Couturier; François Radvanyi; Eytan Domany; Xavier Sastre-Garau
Journal:  Oncogene       Date:  2005-10-27       Impact factor: 9.867

3.  Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage.

Authors:  Randi G Syljuåsen; Claus Storgaard Sørensen; Lasse Tengbjerg Hansen; Kasper Fugger; Cecilia Lundin; Fredrik Johansson; Thomas Helleday; Maxwell Sehested; Jiri Lukas; Jiri Bartek
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 4.  Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile.

Authors:  Claudia Schoch; Wolfgang Kern; Alexander Kohlmann; Wolfgang Hiddemann; Susanne Schnittger; Torsten Haferlach
Journal:  Genes Chromosomes Cancer       Date:  2005-07       Impact factor: 5.006

5.  Pir51, a Rad51-interacting protein with high expression in aggressive lymphoma, controls mitomycin C sensitivity and prevents chromosomal breaks.

Authors:  Sarah E Henson; Shih-Chang Tsai; Cindy Sue Malone; Shahe V Soghomonian; Yan Ouyang; Randolph Wall; York Marahrens; Michael A Teitell
Journal:  Mutat Res       Date:  2006-08-21       Impact factor: 2.433

6.  A novel nucleic acid-binding protein that interacts with human rad51 recombinase.

Authors:  O V Kovalenko; E I Golub; P Bray-Ward; D C Ward; C M Radding
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

7.  Characterization of homologous recombination induced by replication inhibition in mammalian cells.

Authors:  Y Saintigny; F Delacôte; G Varès; F Petitot; S Lambert; D Averbeck; B S Lopez
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

8.  Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase.

Authors:  Eva Petermann; Apolinar Maya-Mendoza; George Zachos; David A F Gillespie; Dean A Jackson; Keith W Caldecott
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

9.  Disparate requirements for the Walker A and B ATPase motifs of human RAD51D in homologous recombination.

Authors:  Claudia Wiese; John M Hinz; Robert S Tebbs; Peter B Nham; Salustra S Urbin; David W Collins; Larry H Thompson; David Schild
Journal:  Nucleic Acids Res       Date:  2006-05-22       Impact factor: 16.971

10.  HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.

Authors:  Cindy A Wilson; Elaina E Cajulis; Jennifer L Green; Taylor M Olsen; Young Ah Chung; Michael A Damore; Judy Dering; Frank J Calzone; Dennis J Slamon
Journal:  Breast Cancer Res       Date:  2005-11-08       Impact factor: 6.466

View more
  15 in total

1.  The USP1-UAF1 complex interacts with RAD51AP1 to promote homologous recombination repair.

Authors:  Scott Cukras; Euiho Lee; Emily Palumbo; Pamela Benavidez; George-Lucian Moldovan; Younghoon Kee
Journal:  Cell Cycle       Date:  2016-07-27       Impact factor: 4.534

Review 2.  Role of RAD51AP1 in homologous recombination DNA repair and carcinogenesis.

Authors:  Elena Pires; Patrick Sung; Claudia Wiese
Journal:  DNA Repair (Amst)       Date:  2017-09-22

3.  Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability.

Authors:  Kelly S Trego; Torsten Groesser; Albert R Davalos; Ann C Parplys; Weixing Zhao; Michael R Nelson; Ayesu Hlaing; Brian Shih; Björn Rydberg; Janice M Pluth; Miaw-Sheue Tsai; Jan H J Hoeijmakers; Patrick Sung; Claudia Wiese; Judith Campisi; Priscilla K Cooper
Journal:  Mol Cell       Date:  2016-01-28       Impact factor: 17.970

4.  RAD51AP1 Deficiency Reduces Tumor Growth by Targeting Stem Cell Self-Renewal.

Authors:  Allison E Bridges; Sabarish Ramachandran; Rajneesh Pathania; Utkarsh Parwal; Adrienne Lester; Pragya Rajpurohit; Daley S Morera; Nikhil Patel; Nagendra Singh; Hasan Korkaya; Santhakumar Manicassamy; Puttur D Prasad; Vinata B Lokeshwar; Bal L Lokeshwar; Vadivel Ganapathy; Muthusamy Thangaraju
Journal:  Cancer Res       Date:  2020-07-14       Impact factor: 13.312

5.  Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers.

Authors:  Dimple Chudasama; Valeria Bo; Marcia Hall; Vladimir Anikin; Jeyarooban Jeyaneethi; Jane Gregory; George Pados; Allan Tucker; Amanda Harvey; Ryan Pink; Emmanouil Karteris
Journal:  Carcinogenesis       Date:  2018-03-08       Impact factor: 4.944

Review 6.  Clinical utility of hyperbaric oxygen therapy in dentistry.

Authors:  Kaitlyn Re; Shrey Patel; Jason Gandhi; Yiji Suh; Inefta Reid; Gunjan Joshi; Noel L Smith; Sardar Ali Khan
Journal:  Med Gas Res       Date:  2019 Apr-Jun

7.  RAD51AP1 Loss Attenuates Colorectal Cancer Stem Cell Renewal and Sensitizes to Chemotherapy.

Authors:  Allison E Bridges; Sabarish Ramachandran; Kavin Tamizhmani; Utkarsh Parwal; Adrienne Lester; Pragya Rajpurohit; Daley S Morera; Sarrah L Hasanali; Pachiappan Arjunan; Ravirajsinh N Jedeja; Nikhil Patel; Pamela M Martin; Hasan Korkaya; Nagendra Singh; Santhakumar Manicassamy; Puttur D Prasad; Vinata B Lokeshwar; Bal L Lokeshwar; Vadivel Ganapathy; Muthusamy Thangaraju
Journal:  Mol Cancer Res       Date:  2021-06-07       Impact factor: 5.852

8.  PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response.

Authors:  Stephanie Wurster; Fabian Hennes; Ann C Parplys; Jasna I Seelbach; Wael Y Mansour; Alexandra Zielinski; Cordula Petersen; Till S Clauditz; Adrian Münscher; Anna A Friedl; Kerstin Borgmann
Journal:  Oncotarget       Date:  2016-03-01

9.  NUCKS1 is a novel RAD51AP1 paralog important for homologous recombination and genome stability.

Authors:  Ann C Parplys; Weixing Zhao; Neelam Sharma; Torsten Groesser; Fengshan Liang; David G Maranon; Stanley G Leung; Kirsten Grundt; Eloïse Dray; Rupa Idate; Anne Carine Østvold; David Schild; Patrick Sung; Claudia Wiese
Journal:  Nucleic Acids Res       Date:  2015-08-31       Impact factor: 16.971

10.  Vero Cells as a Mammalian Cell Substrate for Human Norovirus.

Authors:  Kyle V Todd; Ralph A Tripp
Journal:  Viruses       Date:  2020-04-14       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.